Cervenakova Larisa, Saá Paula, Yakovleva Oksana, Vasilyeva Irina, de Castro Jorge, Brown Paul, Dodd Roger
Scientific Affairs, American National Red Cross, Rockville, Maryland, USA.
Scientific Affairs, American National Red Cross, Rockville, Maryland, USA.
Transfus Apher Sci. 2016 Aug;55(1):70-83. doi: 10.1016/j.transci.2016.07.013. Epub 2016 Jul 18.
Blood has been shown to contain disease-associated misfolded prion protein (PrP(TSE)) in animals naturally and experimentally infected with various transmissible spongiform encephalopathy (TSE) agents, and in humans infected with variant Creutzfeldt-Jakob disease (vCJD). Recently, we have demonstrated PrP(TSE) in extracellular vesicle preparations (EVs) containing exosomes from plasma of mice infected with mouse-adapted vCJD by Protein Misfolding Cyclic Amplification (PMCA). Here we report the detection of PrP(TSE) by PMCA in EVs from plasma of mice infected with Fukuoka-1 (FU), an isolate from a Gerstmann-Sträussler-Scheinker disease patient. We used Tga20 transgenic mice that over-express mouse cellular prion protein, to assay by intracranial injections the level of infectivity in a FU-infected brain homogenate from wild-type mice (FU-BH), and in blood cellular components (BCC), consisting of red blood cells, white blood cells and platelets, plasma EVs, and plasma EVs subjected to multiple rounds of PMCA. Only FU-BH and plasma EVs from FU-infected mice subjected to PMCA that contained PrP(TSE) transmitted disease to Tga20 mice. Plasma EVs not subjected to PMCA and BCC from FU-infected mice failed to transmit disease. These findings confirm the high sensitivity of PMCA for PrP(TSE) detection in plasma EVs and the efficiency of this in vitro method to produce highly infectious prions. The results of our study encourage further research to define the role of EVs and, more specifically exosomes, as blood-borne carriers of PrP(TSE).
在自然感染和实验感染各种传染性海绵状脑病(TSE)病原体的动物以及感染变异型克雅氏病(vCJD)的人类中,血液已被证明含有与疾病相关的错误折叠朊病毒蛋白(PrP(TSE))。最近,我们通过蛋白质错误折叠循环扩增(PMCA)在含有来自感染小鼠适应型vCJD小鼠血浆中外泌体的细胞外囊泡制剂(EVs)中证实了PrP(TSE)的存在。在此,我们报告通过PMCA在感染了来自一名格斯特曼-施特劳斯勒-谢林克病患者分离株福冈-1(FU)的小鼠血浆EVs中检测到PrP(TSE)。我们使用过表达小鼠细胞朊病毒蛋白的Tga20转基因小鼠,通过颅内注射来测定来自野生型小鼠的FU感染脑匀浆(FU-BH)、由红细胞、白细胞和血小板组成的血细胞成分(BCC)、血浆EVs以及经过多轮PMCA处理的血浆EVs中的感染性水平。只有来自经过PMCA处理且含有PrP(TSE)的FU感染小鼠的FU-BH和血浆EVs将疾病传播给了Tga20小鼠。未经PMCA处理的FU感染小鼠的血浆EVs和BCC未能传播疾病。这些发现证实了PMCA在检测血浆EVs中PrP(TSE)方面的高灵敏度以及这种体外方法产生高传染性朊病毒的效率。我们的研究结果鼓励进一步开展研究,以确定EVs,更具体地说是外泌体,作为PrP(TSE)血源载体的作用。